Microbot Medical Inc. (NASDAQ: MBOT) Stock Information | RedChip

Microbot Medical Inc. (NASDAQ: MBOT) Listen to this Section


$1.03
+0.0250 ( +2.50% ) 98.5K

Microbot Medical Inc is a pre-clinical medical device company. It specializes in developing next-generation micro-robotic medical technologies that can change the future of medicine. Their vision is to improve the quality of life of millions of patients globally by advancing micro-robotic technologies to perform surgical procedures and offer physicians and their patients less invasive and more precise solutions. The company's innovative platforms LIBERTY and Self-Cleaning Shunt (SCS) are in one of the fastest-growing segments in healthcare. The group continuously develops its technology with the goal to improve surgical outcomes worldwide. The firm presently holds domestic and global patents that strengthen its product portfolio and create barriers of entry.

Market Data


Open


$1.03

Previous close


$1.00

Volume


98.5K

Market cap


$16.28M

Day range


$1.00 - $1.04

52 week range


$0.85 - $2.35

Insider Ownership Transactions

Total Amount Purchased: -577,808.00 | $ -592,253.20

Date Type Amount Purchased Purchaser
2024-02-26 Sale -17500.00 Vaknin Rachel
2024-02-26 Sale -17500.00 Sharon Simon
2024-02-26 Sale -80000.00 Gadot Harel
2024-02-26 Sale -17500.00 Diaz-Cartelle Juan
2023-11-06 Sale -74218.00 Bornstein Yoseph
2023-11-06 Sale -74218.00 Burell Scott R
2023-11-06 Sale -74218.00 Wenderow Tal Baruch
2023-11-06 Sale -74218.00 Stockburger Aileen Ptucha
2023-11-06 Sale -74218.00 Madden Martin J.
2023-11-06 Sale -74218.00 Laxminarain Prattipati

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 39 Aug 14, 2024
8-k 8K-related 15 Aug 13, 2024
8-k 8K-related 15 Aug 01, 2024
8-k 8K-related 15 Jul 18, 2024
8-k 8K-related 15 Jul 09, 2024
8-k 8K-related 15 Jul 08, 2024
8-k 8K-related 15 Jul 03, 2024
8-k 8K-related 16 Jul 01, 2024
8-k 8K-related 16 Jun 17, 2024
8-k 8K-related 20 Jun 04, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.